Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regenerative Effects of Erythropoietin in Burn and Scald Injuries
2006-002886-38Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- Dec 2007
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of epoetin beta in burn injury, Scald and Abnormal wound healing, sponsored by Technical University of Munich. Primary endpoints: Time to complete reepithelialization of split-thickness skin graft donor sites and Time to complete wound healing of type 2a superficial dermal wounds. Started Dec 2007; status: terminated.
02
Drugs
epoetin beta
03
Conditions
burn injuryScaldAbnormal wound healing
Beyond the preview
Go deeper on 2006-002886-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002886-38.